FERI (Luxembourg) S.A.’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
FERI (Luxembourg) S.A.'s BMY Position: Q3 2026 in Review
FERI (Luxembourg) S.A. reduced its Bristol-Myers Squibb (BMY) stake by 50% in Q3 2026, selling an estimated $2.3M and leaving 35,860 shares worth $2.24M. The position accounts for 0.3% of the portfolio, ranked #75.
FERI (Luxembourg) S.A. first reported a position in BMY in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.16M in Q2 2026. 2,416 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- FERI (Luxembourg) S.A. held 35,860 shares of Bristol-Myers Squibb worth $2.24M as of Q3 2026.
- FERI (Luxembourg) S.A. sold 36,380 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.3M.
- Bristol-Myers Squibb made up 0.3% of FERI (Luxembourg) S.A.'s portfolio in Q3 2026, its #75 holding.
- FERI (Luxembourg) S.A. first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 8 quarters since.
- FERI (Luxembourg) S.A.'s Bristol-Myers Squibb position peaked at $4.16M in Q2 2026.
- 2,416 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on FERI (Luxembourg) S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.